By Raf Casert

The discovery of a new coronavirus variant sent a chill through much of the world Friday as nations raced to halt air travel, markets fell sharply and scientists held emergency meetings to weigh the exact risks, which were largely unknown.

A World Health Organization panel named the variant “omicron” and classified it as a highly transmissible virus of concern, the same category that includes the delta variant. The WHO suggested the variant could pose greater risks than delta, which is the world’s most prevalent variant and has fueled relentless waves of infection on every continent.

Early evidence suggests an increased risk of reinfection compared to other highly transmissible variants, the WHO said. That means people who contracted COVID-19 and recovered could be subject to catching it again.

In response, the United States and Canada joined the European Union and several other countries in instituting travel restrictions on visitors from southern Africa.

The White House said the U.S. will restrict travel from South Africa and seven other countries in the region beginning Monday. It did not give details except to say the restrictions will not apply to returning U.S. citizens or permanent residents, who will continue to be required to test negative before their travel.

Medical experts, including the WHO, warned against any overreaction before the variant that originated in southern Africa was better understood. But a jittery world feared the worst nearly two years after COVID-19 emerged and triggered a pandemic that has killed more than 5 million people around the globe.

“We must move quickly and at the earliest possible moment,” British Health Secretary Sajid Javid told lawmakers.

There was no immediate indication whether the variant causes more severe disease. As with other variants, some infected people display no symptoms, South African experts said. The WHO panel drew from the Greek alphabet in naming the variant omicron, as it has done with earlier, major variants of the virus.

Even though some of the genetic changes appear worrisome, it was unclear if the new variant would pose a significant public health threat. Some previous variants, like the beta variant, initially concerned scientists but did not spread very far.

The 27-nation European Union imposed a temporary ban on air travel from southern Africa, and stocks tumbled in Asia, Europe and the United States. The Dow Jones Industrial Average dropped more than 1,000 points. The S&P 500 index was down 2.3%, on pace for its worst day since February. The price of oil plunged nearly 12%.

“The last thing we need is to bring in a new variant that will cause even more problems,” German Health Minister Jens Spahn said. The member nations of the EU have experienced a massive spike in cases recently.

EU Commission President Ursula von der Leyen said flights will have to “be suspended until we have a clear understanding about the danger posed by this new variant, and travelers returning from this region should respect strict quarantine rules.”

She insisted on extreme caution, warning that “mutations could lead to the emergence and spread of even more concerning variants of the virus that could spread worldwide within a few months."

Belgium became the first European Union country to announce a case of the variant.

“It’s a suspicious variant," Health Minister Frank Vandenbroucke said. “We don’t know if it’s a very dangerous variant.”

It has yet to be detected in the United States, said Dr. Anthony Fauci, the U.S. government's top infectious disease expert. Abroad, the variant “seems to be spreading at a reasonably rapid rate,” he told CNN. And although it may be more transmissible and resistant to vaccines than other variants, "we don’t know that for sure right now.”

Showing how complicated the spread of a variant can be, the Belgian case involved a traveler who returned to Belgium from Egypt on Nov. 11 but did not became sick with mild symptoms until Monday, according to professor Marc Van Ranst, who works for the scientific group overseeing the Belgian government's COVID-19 response.

Israel, one of the world's most vaccinated countries, announced Friday that it also detected its first case of the new variant in a traveler who returned from Malawi. The traveler and two other suspected cases were placed in isolation. Israel said all three were vaccinated, but officials were looking into the travelers' exact vaccination status.

After a 10-hour overnight trip, passengers aboard KLM Flight 598 from Capetown, South Africa, to Amsterdam were held on the edge of the runway Friday morning at Schiphol airport for four hours pending special testing. Passengers aboard a flight from Johannesburg were also being isolated and tested.

“It’s ridiculous. If we didn’t catch the dreaded bug before, we're catching it now,” said passenger Francesca de’ Medici, a Rome-based art consultant who was on the flight.

Some experts said the variant's emergence illustrated how rich countries’ hoarding of vaccines threatens to prolong the pandemic.

Fewer than 6% of people in Africa have been fully immunized against COVID-19, and millions of health workers and vulnerable populations have yet to receive a single dose. Those conditions can speed up spread of the virus, offering more opportunities for it to evolve into a dangerous variant.

“This is one of the consequences of the inequity in vaccine rollouts and why the grabbing of surplus vaccines by richer countries will inevitably rebound on us all at some point,” said Michael Head, a senior research fellow in global health at Britain’s University of Southampton. He urged Group of 20 leaders "to go beyond vague promises and actually deliver on their commitments to share doses.”

The new variant added to investor anxiety that months of progress containing COVID-19 could be reversed.

“Investors are likely to shoot first and ask questions later until more is known,” said Jeffrey Halley of foreign exchange broker Oanda.

In a sign of how concerned Wall Street has become, the market’s so-called fear gauge known as the VIX jumped 48% to a reading of 26.91. That’s the highest reading for the volatility index since January, before vaccines were widely distributed.

Speaking before the EU announcement, Dr. Michael Ryan, head of emergencies at the WHO, warned against "knee-jerk responses."

“We’ve seen in the past, the minute there’s any kind of mention of any kind of variation and everyone is closing borders and restricting travel," Ryan said. “It’s really important that we remain open and stay focused.”

The Africa Centers for Disease Control and Prevention agreed and strongly discouraged any travel bans on countries that reported the new variant. It said past experience shows that such travel bans have “not yielded a meaningful outcome.”

Yet the U.S. announced restrictions on visitors from South Africa, Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique, and Malawi, hours after governments took similar steps.

The U.K. banned flights from South Africa and five other southern African countries at noon on Friday and announced that anyone who had recently arrived from those countries would be asked to take a coronavirus test.

Canada banned the entry of all foreigners who have traveled to southern Africa in the last two weeks.

The Japanese government announced that Japanese nationals traveling from Eswatini, Zimbabwe, Namibia, Botswana, South Africa and Lesotho will have to quarantine at government-dedicated accommodations for 10 days and take three COVID-19 tests during that time. Japan has not yet opened up to foreign nationals.

Fauci said U.S. public health officials were talking Friday with South African colleagues. "We want to find out scientist to scientist exactly what is going on.”

The WHO’s technical working group says coronavirus infections jumped 11% in the past week in Europe, the only region in the world where COVID-19 continues to rise.

The WHO’s Europe director, Dr. Hans Kluge, warned that without urgent measures, the continent could see an additional 700,000 deaths by the spring.

____

Associated Press writers Lorne Cook in Brussels, Colleen Barry in Milan, Pan Pylas in London, Jamey Keaten in Geneva, Mike Corder in The Hague, Dave McHugh in Frankfurt, Carley Petesch in Dakar, Andrew Meldrum in Johannesburg and Frank Jordans in Berlin contributed to this report.

Updated on November 26, 2021, at 2:38 p.m. ET with the latest details.

Share:
More In Science
3D Printed, D2C Prosthetics; Future of Human-Robot Collaboration
On this episode of Cheddar Innovates: Founder of Unlimited Tomorrow breaks down how he is creating completely 3D printed prosthetics to make them more affordable, customizable, and accessible; Chief Technology Officer of Zebra Technologies explains what the future of collaboration between robots and humans may look like; A look at Curiosity Stream's 'Mystery of the Roman Skulls.'
The Promise of 'Treg' Cells In ALS Treatments
Each year about 5,000 people are diagnosed with ALS. This is such an important conversation. A disease that can weaken a patient's muscles and impact physical function. However, one research company says that could all change soon. Coya Therapeutics has developed a way to isolate a patient problematic T-cells in order to help ultimately slow the decline of not just ALS, but potentially Alzheimer's and other neurodegenerative diseases as well. Founder and Chief Executive Officer at Coya Therapeutics, Dr. Howard Berman, joined Cheddar to discuss more.
Hydrogen Expected to Play Important Part in Achieving Net-Zero Future
In the fight against climate change, much of the conversation revolves around reducing greenhouse gases like carbon dioxide or methane - and attempting to raise oxygen levels. But there's another gas - hydrogen - that could play a big role in the fight for the climate. Marco Alvera, CEO of Italian energy infrastructure company Snam and author of the book, 'The Hydrogen Revolution,' joined Cheddar Climate to explain the role hydrogen plays in helping achieve a net-zero future.
Walmart, Kroger Raise At-Home COVID-19 Test Prices
Americans looking to purchase at-home COVID-19 tests will now have to shell out a bit more money after an agreement expired between the White House and companies to sell the tests at cost. The price of Abbot's BinaxNow test kit from October to December was $14 apiece; on Tuesday, Walmart's website listed the test for $19.88, and Kroger listed the tests for $23.99. Carbon Health Regional Clinical Director Dr. Bayo Curry-Winchell joined Cheddar News' Closing Bell to discuss the impact higher prices will have as the nation experiences another surge in cases.
Kids Head Back To School As Omicron Surges In NYC
As millions of kids go back to school, districts across the country are determined to keep class in person, despite a surge in COVID cases. In New York City, Mayor Eric Adams has vowed to keep the nation's largest school system open amid Omicron, citing the disastrous effect of remote learning on students. Oswald Feliz, NYC council member who sits on the health and education committee, joined Cheddar to discuss the city's plan to combat the recent surge and keep kids in school.
How Schools Are Preparing For Omicron
Schools across the country are determined to keep class in session, despite the rapidly-spreading Omicron variant. While many parents prefer in-person learning, they also worry whether the current public health guidelines will be enough to protect their kids. Erin Richards, national education reporter for USA Today, joined Cheddar to discuss how are schools are preparing for the surge to avoid another round of remote learning.
HP on New Products at CES 2022, Challenge of Reaching Carbon Net Zero by 2040
With the annual CES convention underway amid COVID, HP unveiled rolled out a number of new products virtually this year, including new gaming PCs and 4K display monitors. But as industries look toward a greener future, HP is working with the climate crisis in mind. James McCall, chief sustainability officer at HP, joined Cheddar's Kristen Scholer to discuss the company's climate goals, which includes reducing its carbon footprint to net-zero by 2040. He admitted that reaching the ambitious goal will be difficult because much of the company's emissions totals come from third parties. "A large part of our footprint is outside of HP's direct control. A lot of it comes either from our incoming supply chain, the materials, our manufacturing process, or about 30 to 40 percent of it comes from our consumer-use base," McCall told Cheddar.
Pfizer, BioNTech to Develop mRNA Shingles Vaccine
Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies have worked together on a vaccine.
Researchers Travel to "Doomsday" Thwaites Glacier to Test Ocean Temperature
The potential collapse of the Thwaites glacier in Antarctica has been deemed a potential "doomsday event" — researchers and scientists say its melting and collapse could raise global sea levels by at least two feet, enough to destroy coastal communities around the world. One team of scientists is traveling to the Thwaites glacier to drill below in order to gauge current ocean temperatures and attempt to model possible outcomes. David Holland, professor at NYU and Principal Investigator for the International Thwaites Glacier Collaboration, joins Cheddar Climate to discuss the glacier's potential collapse, his team's research plan, and more.
Schools Prepare to Reopen Despite Rising Covid Cases
As winter break wraps up and COVID-19 cases hit record levels, the majority of school districts are returning to in-person classes. While some public schools in large cities have shifted to remote learning for the beginning of the year, the schools that are reopening campuses are determined to avoid the academic, social, and logistical challenges that come with a virtual classroom. Cheddar News is joined by Keith Powers, NYC Council Member, to discuss.
Load More